drugset / Trial / NCT02374437

Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol and Food Effect in Healthy Volunteers

NCT02374437

Phase 1 Completed 66 enrolled Galmed Pharmaceuticals Ltd
RandomizedParallel-groupQuadruple-blind

Summary

This is a single-site, randomized, partly double-blind, placebo-controlled study of Aramchol in sixty six (66) healthy male volunteers. In each part of the study subjects will be enrolled in the study within 28 days before drug administration(s). The study will consist of three parts and the subjects will be assigned to three Parts.

Timeline

Start
2014-04
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aramchol Other / unclassified 200 mg
Comparator Aramchol Other / unclassified 400 mg
Comparator Aramchol Other / unclassified 600 mg

Indications

No indication recorded.